10:45 AM EST - Ondine Biomedical Inc. : announced its financial results for 2010. The Company recorded a loss of $3.26 million, or $0.40 per common share, a decrease of $1.34 million (29%) when compared with the loss of $4.60 million, or $0.83 per common share, for the year ended December 31, 2009. Product sales revenue for Periowave(TM) laser base stations (LBS), hand held lasers (HHL) and treatment kits (TKS) for the Current Year was $450,000, generating a gross margin of $130,000 (30.1%), compared to product sales of LBS and TKS of $0.58 million and gross profit margin of $360,000 (62.3%) for the Prior Year. Ondine Biomedical Inc.
shares T.OBP are trading up $0.02 at $0.32.
